5-13876779-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001369.3(DNAH5):​c.3301G>A​(p.Val1101Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00286 in 1,613,508 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1101A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 48 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 55 hom. )

Consequence

DNAH5
NM_001369.3 missense

Scores

2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.88

Publications

8 publications found
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032642782).
BP6
Variant 5-13876779-C-T is Benign according to our data. Variant chr5-13876779-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 163153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.014 (2123/152016) while in subpopulation AFR AF = 0.0467 (1937/41444). AF 95% confidence interval is 0.045. There are 48 homozygotes in GnomAd4. There are 1003 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 48 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001369.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAH5
NM_001369.3
MANE Select
c.3301G>Ap.Val1101Met
missense
Exon 22 of 79NP_001360.1
DNAH5-AS1
NR_199035.1
n.117+16224C>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAH5
ENST00000265104.5
TSL:1 MANE Select
c.3301G>Ap.Val1101Met
missense
Exon 22 of 79ENSP00000265104.4
DNAH5
ENST00000681290.1
c.3256G>Ap.Val1086Met
missense
Exon 22 of 79ENSP00000505288.1
DNAH5-AS1
ENST00000503244.2
TSL:4
n.253+16224C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0139
AC:
2110
AN:
151898
Hom.:
48
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0466
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00879
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00388
AC:
974
AN:
250794
AF XY:
0.00300
show subpopulations
Gnomad AFR exome
AF:
0.0489
Gnomad AMR exome
AF:
0.00345
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000300
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00171
AC:
2497
AN:
1461492
Hom.:
55
Cov.:
31
AF XY:
0.00148
AC XY:
1078
AN XY:
727056
show subpopulations
African (AFR)
AF:
0.0517
AC:
1731
AN:
33450
American (AMR)
AF:
0.00336
AC:
150
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86246
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53408
Middle Eastern (MID)
AF:
0.00366
AC:
21
AN:
5744
European-Non Finnish (NFE)
AF:
0.000298
AC:
331
AN:
1111778
Other (OTH)
AF:
0.00406
AC:
245
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
115
231
346
462
577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2123
AN:
152016
Hom.:
48
Cov.:
33
AF XY:
0.0135
AC XY:
1003
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0467
AC:
1937
AN:
41444
American (AMR)
AF:
0.00878
AC:
134
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4800
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10542
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68000
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
102
204
305
407
509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00496
Hom.:
16
Bravo
AF:
0.0162
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0409
AC:
180
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00456
AC:
554
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Primary ciliary dyskinesia (3)
-
-
3
Primary ciliary dyskinesia 3 (3)
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.062
T
Eigen
Benign
0.058
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0033
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
PhyloP100
1.9
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.030
Sift
Benign
0.22
T
Polyphen
0.33
B
Vest4
0.25
MVP
0.45
MPC
0.31
ClinPred
0.012
T
GERP RS
4.6
Varity_R
0.043
gMVP
0.16
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61747516; hg19: chr5-13876888; COSMIC: COSV54230916; API